Clinical Trial Update: PHP in Combination With IPI1/NIVO3 Compared to IPI3/NIVO1 Only in Patients With Uveal Melanoma Liver Metastases [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating PHP in combination with ipilimumab and nivolumab versus ipilimumab and nivolumab alone in patients with uveal melanoma and liver metast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Metastases
• Uveal Melanoma

Drugs mentioned

• PHP
• ipilimumab (ipilimumab)
• nivolumab (nivolumab)

Snippet

Sponsor: Vastra Gotaland Region | Conditions: Uveal Melanoma, Liver Metastases | Phase 3 | Status: RECRUITING